Insiders · Profile

YANCOPOULOS GEORGE

Bd. Co-Chair, President & CSO at Regeneron Pharmaceuticals. Filing since 3 Jan 2007. CIK 0001226690

Company

Date

Role

Action

Shares

Amount

Of holding

REGN Regeneron Pharmaceuticals

16 May 2024

Bd. Co-Chair, President & CSO

Sold on a plan

50,000

$48.64M

6.0%

REGN Regeneron Pharmaceuticals

15 May 2024

Bd. Co-Chair, President & CSO

Sold on a plan

50,000

$48.79M

5.6%

REGN Regeneron Pharmaceuticals

2 Jan 2024

Bd. Co-Chair, President & CSO

Sold on a plan

33,696

$30.33M

15.8%

REGN Regeneron Pharmaceuticals

23 Mar 2023

President and Chief Scientific

Sold on a plan

3,656

$2.94M

1.8%

REGN Regeneron Pharmaceuticals

6 Feb 2023

President and Chief Scientific

Sold, plan not stated

13,189

$10.55M

6.2%

REGN Regeneron Pharmaceuticals

16 Aug 2021

President and Chief Scientific

Sold, plan not stated

49,227

$30.78M

5.3%

REGN Regeneron Pharmaceuticals

13 Aug 2021

President and Chief Scientific

Sold, plan not stated

773

$483.13K

0.1%

REGN Regeneron Pharmaceuticals

5 Aug 2021

President and Chief Scientific

Sold, plan not stated

50,000

$30.00M

5.1%

REGN Regeneron Pharmaceuticals

21 Jun 2021

President and Chief Scientific

Sold, plan not stated

80,000

$43.11M

97.4%

REGN Regeneron Pharmaceuticals

10 Mar 2020

President and Chief Scientific

Sold, plan not stated

117,815

$55.43M

18.5%

REGN Regeneron Pharmaceuticals

24 Feb 2020

President and Chief Scientific

Sold, plan not stated

118,123

$49.63M

18.6%

REGN Regeneron Pharmaceuticals

2 Dec 2015

President Regeneron Laboratori

Sold, plan not stated

43,348

$23.80M

8.0%

REGN Regeneron Pharmaceuticals

2 Nov 2015

President Regeneron Laboratori

Sold, plan not stated

43,348

$24.78M

7.4%

REGN Regeneron Pharmaceuticals

12 Feb 2014

President Regeneron Laboratori

Sold, plan not stated

88,987

$28.50M

7.7%

REGN Regeneron Pharmaceuticals

7 May 2013

President Regeneron Laboratori

Sold, plan not stated

100,000

$26.26M

8.3%

REGN Regeneron Pharmaceuticals

1 May 2012

EVP CSO President Regeneron Re

Sold, plan not stated

33,165

$4.47M

3.8%

REGN Regeneron Pharmaceuticals

26 Mar 2012

EVP CSO President Regeneron Re

Sold, plan not stated

33,150

$3.99M

3.7%

REGN Regeneron Pharmaceuticals

5 Jan 2012

EVP, CSO & Pres, REGN Res Labs

Sold, plan not stated

27,713

$1.61M

3.2%

REGN Regeneron Pharmaceuticals

1 Dec 2011

EVP CSO President Regeneron Re

Sold, plan not stated

27,713

$1.65M

3.0%

REGN Regeneron Pharmaceuticals

16 Dec 2008

EVP, CSO, & Pres Regn Res Labs

Sold, plan not stated

26,991

$442.65K

4.6%

REGN Regeneron Pharmaceuticals

16 Apr 2007

EVP, CSO, & Pres Regn Res Labs

Sold, plan not stated

31,283

$768.00K

31.8%

REGN Regeneron Pharmaceuticals

9 Apr 2007

EVP, CSO, & Pres Regn Res Labs

Sold, plan not stated

9,556

$227.63K

12.5%

REGN Regeneron Pharmaceuticals

4 Jan 2007

EVP, CSO, & Pres Regn Res Labs

Sold, plan not stated

3,882

$77.64K

5.5%

REGN Regeneron Pharmaceuticals

3 Jan 2007

EVP, CSO, & Pres Regn Res Labs

Sold, plan not stated

19,123

$382.87K

22.3%

24 decisions on file.